These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


503 related items for PubMed ID: 23782526

  • 1. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L, Gimeno-Blanes JR, Rodríguez-García MI, Monserrat L, Zorio E, Coats C, McGregor CG, Hernandez del Rincón JP, Castro-Beiras A, Hermida-Prieto M.
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [Abstract] [Full Text] [Related]

  • 2. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR, Chu CT, Charng MJ.
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [Abstract] [Full Text] [Related]

  • 3. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
    Mori AA, Castro LR, Bortolin RH, Bastos GM, Oliveira VF, Ferreira GM, Hirata TDC, Fajardo CM, Sampaio MF, Moreira DAR, Pachón-Mateos JC, Correia EB, Sousa AGMR, Brión M, Carracedo A, Hirata RDC, Hirata MH.
    Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F, Kayvanpour E, Tugrul OF, Lai A, Amr A, Haas J, Proctor T, Ehlermann P, Jensen K, Katus HA, Meder B.
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study.
    Mattos BP, Scolari FL, Torres MA, Simon L, Freitas VC, Giugliani R, Matte Ú.
    Arq Bras Cardiol; 2016 Sep; 107(3):257-265. PubMed ID: 27737317
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS, Havndrup O, Hougs L, Sørensen KM, Jensen M, Larsen LA, Hedley P, Thomsen AR, Moolman-Smook J, Christiansen M, Bundgaard H.
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [Abstract] [Full Text] [Related]

  • 7. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
    Nakashima Y, Kubo T, Sugiura K, Ochi Y, Takahashi A, Baba Y, Hirota T, Yamasaki N, Kimura A, Doi YL, Kitaoka H.
    Circ J; 2020 Sep 25; 84(10):1846-1853. PubMed ID: 32830170
    [Abstract] [Full Text] [Related]

  • 8. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT, Nguyen TV, Huynh NV, Nguyen Thai HT, Pham Nguyen V, Ho Huynh TD.
    Circ J; 2019 Aug 23; 83(9):1908-1916. PubMed ID: 31308319
    [Abstract] [Full Text] [Related]

  • 9. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F, Olivotto I, Passerini I, Zachara E, Nistri S, Re F, Fantini S, Baldini K, Torricelli F, Cecchi F.
    J Cardiovasc Med (Hagerstown); 2006 Aug 23; 7(8):601-7. PubMed ID: 16858239
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy.
    Otsuka H, Arimura T, Abe T, Kawai H, Aizawa Y, Kubo T, Kitaoka H, Nakamura H, Nakamura K, Okamoto H, Ichida F, Ayusawa M, Nunoda S, Isobe M, Matsuzaki M, Doi YL, Fukuda K, Sasaoka T, Izumi T, Ashizawa N, Kimura A.
    Circ J; 2012 Aug 23; 76(2):453-61. PubMed ID: 22112859
    [Abstract] [Full Text] [Related]

  • 11. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
    Sequeira V, Wijnker PJ, Nijenkamp LL, Kuster DW, Najafi A, Witjas-Paalberends ER, Regan JA, Boontje N, Ten Cate FJ, Germans T, Carrier L, Sadayappan S, van Slegtenhorst MA, Zaremba R, Foster DB, Murphy AM, Poggesi C, Dos Remedios C, Stienen GJ, Ho CY, Michels M, van der Velden J.
    Circ Res; 2013 May 24; 112(11):1491-505. PubMed ID: 23508784
    [Abstract] [Full Text] [Related]

  • 12. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
    Selvi Rani D, Nallari P, Dhandapany PS, Rani J, Meraj K, Ganesan M, Narasimhan C, Thangaraj K.
    DNA Cell Biol; 2015 May 24; 34(5):350-9. PubMed ID: 25607779
    [Abstract] [Full Text] [Related]

  • 13. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD, Credidio FL, de Oliveira TG, Reis RF, Antunes Mde O, de Araujo AQ, Pedrosa RP, Barbosa-Ferreira JM, Mady C, Krieger JE, Arteaga-Fernandez E, Pereira Ada C.
    Am Heart J; 2013 Oct 24; 166(4):775-82. PubMed ID: 24093860
    [Abstract] [Full Text] [Related]

  • 14. [Mutations in genes for sarcomeric proteins].
    Kimura A.
    Nihon Rinsho; 2000 Jan 24; 58(1):117-22. PubMed ID: 10885298
    [Abstract] [Full Text] [Related]

  • 15. Spectrum of Mutations in Hypertrophic Cardiomyopathy Genes Among Tunisian Patients.
    Jaafar N, Gómez J, Kammoun I, Zairi I, Amara WB, Kachboura S, Kraiem S, Hammami M, Iglesias S, Alonso B, Coto E.
    Genet Test Mol Biomarkers; 2016 Nov 24; 20(11):674-679. PubMed ID: 27574918
    [Abstract] [Full Text] [Related]

  • 16. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
    Ntusi NA, Shaboodien G, Badri M, Gumedze F, Mayosi BM.
    Cardiovasc J Afr; 2016 Nov 24; 27(3):152-158. PubMed ID: 27841901
    [Abstract] [Full Text] [Related]

  • 17. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD, Padrón R.
    Invest Clin; 2004 Mar 24; 45(1):69-99. PubMed ID: 15058760
    [Abstract] [Full Text] [Related]

  • 18. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S, Lança V, Oliveira H, Branco P, Silveira L, Marques V, Brito D, Madeira H, Bicho M, Fernandes AR.
    Rev Port Cardiol; 2011 Jan 24; 30(1):7-18. PubMed ID: 21425739
    [Abstract] [Full Text] [Related]

  • 19. A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P, Heliö T, Aalto-Setälä K, Kaartinen M, Ilveskoski E, Hämäläinen L, Melin J, Kärkkäinen S, Peuhkurinen K, Nieminen MS, Laakso M, FinHCM Study Group, Kuusisto J.
    Ann Med; 2014 Sep 24; 46(6):424-9. PubMed ID: 24888384
    [Abstract] [Full Text] [Related]

  • 20. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy.
    Erdmann J, Daehmlow S, Wischke S, Senyuva M, Werner U, Raible J, Tanis N, Dyachenko S, Hummel M, Hetzer R, Regitz-Zagrosek V.
    Clin Genet; 2003 Oct 24; 64(4):339-49. PubMed ID: 12974739
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.